Tissue-sparing laser therapy

Iridex have launched a non-invasive, in-office glaucoma procedure based on the MicroPulse technology.

Related Content:

Articles

Application for Genentech’s faricimab accepted by U.S. FDA for treatment of wet AMD and DMO

Expanding the definition of AMD

Combined MIGS and cataract surgery option offers positive results